Impact of Anti PD-1 Therapy in Children, Adolescents and Young Adults (CAYA) Melanoma Patients
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Clinical Trials Related to Advanced Melanoma
Related studies linked through entity extraction aliases.
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
- Status
- RECRUITING
- Phase
- PHASE3
A Clinical Study of T3011 in Subjects With Advanced Melanoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Clinical Study of the Pharmacokinetics and Safety of BCD-263 and Opdivo® as Monotherapy in Subjects With Advanced Melanoma of the Skin
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
- Status
- RECRUITING
- Phase
- PHASE3
At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Naltrexone and Propranolol Combined With Immunotherapy
- Status
- RECRUITING
- Phase
- PHASE1
The Immune Effects of Fermented Wheat Germ Nutritional Supplementation in Patients With Advanced Solid Tumor Cancers Being Treated With Standard of Care Checkpoint Inhibitors
- Status
- RECRUITING
- Phase
- PHASE1
ACT-TIL and ANV419 for Advanced Melanoma.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
XmAb23104 (PD1 X ICOS) and XmAb22841 (CTLA-4 X LAG3) in Treating Melanoma Prior Immune Checkpoint Inhibitor Therapy
- Status
- TERMINATED
- Phase
- PHASE1
Prophylactic Mesalamine to Prevent Colitis Following Treatment With Ipilimumab/Nivolumab (Ipi/Nivo)
- Status
- RECRUITING
- Phase
- PHASE2
Memory-Like Natural Killer Cells With Nivolumab and Relatlimab in Advanced or Metastatic Melanoma After Progression on Checkpoint Inhibitors
- Status
- RECRUITING
- Phase
- PHASE1
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
- Status
- RECRUITING
- Phase
- PHASE3
A Study of Botensilimab (AGEN1181) for the Treatment of Advanced Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
PD-1 Antibody Tislelizumab Combined With Dacarbazine in the Treatment of Advanced Melanoma
- Status
- UNKNOWN
- Phase
- PHASE2
Treatment Patterns and Outcomes in Participants With Advanced Melanoma in Germany Using a German Database
- Status
- COMPLETED
- Phase
- N/A
A Study to Evaluate the Safety and Efficacy of CyPep-1 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic Cancers
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Imatinib and Toripalimab in Patients With Locally Advanced/Metastatic Melanoma Harbored With CKIT Mut
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of RC48-ADC in Advanced Melanoma Subjects With HER2 Variant (Mutation, Amplification, Overexpression)
- Status
- RECRUITING
- Phase
- PHASE2
Multicenter Study of Safety and Efficacy of Prolgolimab in Patients With Advanced Melanoma in Routine Clinical Practice
- Status
- UNKNOWN
- Phase
- N/A